Gait Analysis and Clinical Outcomes of Anterior and Lateral Approach Total Hip Arthroplasty.

August 2, 2024 updated by: Ain Shams University

Gait Analysis and Clinical Outcomes of Anterior and Lateral Approach Total Hip Arthroplasty. A Prospective Randomized Study.

The goal of this Prospective Randomized Study is to confirm presence or absence of differences in gait mechanics in direct anterior and lateral approaches for total hip arthroplasty. and to compare the clinical outcomes of both approaches.

The main questions it aims to answer are:

if the anterior approach to the hip is faster recovery than lateral approach? if the anterior approach to the hip has better gait mechanics than lateral approach?

Participants will:

undergo one of the two approaches for total hip arthroplasty. All patients will be followed up at 2 weeks, 6 weeks, 3 months and 18 months. gait analysis will be done at 6wks, 3m, and 18months.

Study Overview

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Abbasia
      • Cairo, Abbasia, Egypt
        • Ain Shams University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with primary osteoarthritis or osteonecrosis of the hip who consented for treatment with a total hip arthroplasty (THA) through an anterior or lateral approach.
  • Age between 20 - 60 years of age.
  • The participant had to be independent and physically active, which characterized as having the capacity to carry out daily tasks, ascend two flights of stairs, and able to walk for 15 minutes.

Exclusion Criteria:

  • Patients with bilateral hip affection.
  • Body mass index (BMI) greater than 40.
  • Diagnosis other than primary osteoarthritis or osteonecrosis.
  • Prior hip or spine surgery.
  • chronic uncontrolled comorbidities, psychological disorders.
  • American Society of Anaesthesiologists score (ASA) higher than 2
  • chronic neurological deficits that influence gait.
  • any limb length discrepancy more than 1 cm.
  • Any postoperative complication that will lead to delay in weight bearing.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: lateral approach group
gait analysis done in the gait lab at the mentioned postoperative periods
In the lateral approach partial detachment of the anterior one-third of the gluteus medius muscle.
Active Comparator: direct anterior approach group
the anterior approach using an internervous plane between the tensor fascia latae and the sartorius muscle.
gait analysis done in the gait lab at the mentioned postoperative periods

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surgery time
Time Frame: intraoperative time starting from skin incision to skin closure
by ''Minute'' as the unit, no special description.
intraoperative time starting from skin incision to skin closure
hemoglobin drop
Time Frame: postoperative day one
hemoglobin drop level between pre and postoperative.
postoperative day one
hospital stays
Time Frame: immediately after the procedure
by ''Day'' as the unit, no special description. postoperative stay days from operation day to discharge day.
immediately after the procedure
pain score
Time Frame: 2 weeks 6 weeks 3 months 18 months
using visual analogue scale (VAS) from 0-10 the more scale the worst the pain
2 weeks 6 weeks 3 months 18 months
Harris hip score
Time Frame: 2 weeks 6 weeks 3 months 18 months
for measuring hip function from 0-100 the more the score the better hip function
2 weeks 6 weeks 3 months 18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gait analysis
Time Frame: at 6 weeks, 3 months, 18 months
A single experienced physical medicine specialist will perform the gait analysis in a gait lab. Three-dimensional kinematic and kinetic data will be collected using eight high-speed infrared cameras (Quality motion analysis system, oqus 1 cameras), which can capture 240 frames per second, two force plates (Advanced Mechanical Technology Incorporated, AMTI), and 26 ten-millimeter passive retroreflective markers fixed on the subject using a double-face tape in specific landmarks on the subject in accordance to the modified institute Orthopedic Rizzoli (IOR ) model for full body marker set.
at 6 weeks, 3 months, 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2021

Primary Completion (Actual)

June 1, 2023

Study Completion (Actual)

July 10, 2023

Study Registration Dates

First Submitted

July 7, 2024

First Submitted That Met QC Criteria

August 2, 2024

First Posted (Estimated)

August 5, 2024

Study Record Updates

Last Update Posted (Estimated)

August 5, 2024

Last Update Submitted That Met QC Criteria

August 2, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • MD 03/2021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Osteoarthritis

Clinical Trials on total hip replacement using anterior approach

Subscribe